SCHEMBL1070026

SCHEMBL1070026

C[N+](=N)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305514 0.72
SCHEMBL2879698 0.72
SCHEMBL29615688 0.67
SCHEMBL28485731 0.67
SCHEMBL28396996 0.67
SCHEMBL28412085 0.67
Ammonia Solution, Strong SCHEMBL4116843 0.67
SCHEMBL2304704 0.67
SCHEMBL28550757 0.64
SCHEMBL3498765 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2456432-B1 COMPOSITIONS TO REDUCE OXIDATIVE STRESS UNIV MASSACHUSETTS (US) 2024-02-28 EP disclosed
WO-2024010404-A1 NOVEL COMPOUND AS PHOSPHOLIPASE D INHIBITOR AND USE THEREOF 연세대학교 산학협력단 2024-01-11 WO disclosed
CN-116999539-A Colorectal cancer immunotherapy drug IFNBCOL01 天津大学 2023-11-07 CN disclosed
US-20230338438-A1 BACTERIAL BIOFILMS AND CANCER THE JOHNS HOPKINS UNIVERSITY (US) 2023-10-26 US disclosed
CN-116916765-A Composition for preventing, improving or treating diseases caused by protein nitrification comprising peptide having tyrosine at its end as active ingredient 庆尚国立大学校 产学协力团 2023-10-20 CN disclosed
CN-113842451-B FAM3D protein and medical application of polynucleotide for encoding same 北京大学 2023-09-19 CN disclosed
US-11730774-B2 Bacterial biofilms and cancer THE JOHNS HOPKINS UNIVERSITY (US) 2023-08-22 US disclosed
CN-115996645-A Composition for preventing, improving or treating diseases caused by nitration of tyrosine in protein comprising tyrosine as active ingredient 庆尚国立大学校 产学协力团 2023-04-21 CN disclosed
US-11090305-B2 Methods and compositions to reduce oxidative stress UNIVERSITY OF MASSACHUSETTS (US) 2021-08-17 US disclosed
US-20200405779-A1 BACTERIAL BIOFILMS AND CANCER THE JOHNS HOPKINS UNIVERSITY (US) 2020-12-31 US disclosed
WO-2013050998-A1 CD247 AS A BIOMARKER FOR ASSESSING THE EFFECT OF CHEMOTHERAPEUTIC AND BIOLOGICAL DRUGS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2013-04-11 WO disclosed
US-20120190731-A1 METHODS AND COMPOSITIONS TO REDUCE OXIDATIVE STRESS UNIVERSITY OF MASSACHUSETTS (US) 2012-07-26 US disclosed
EP-2456432-A1 METHODS AND COMPOSITIONS TO REDUCE OXIDATIVE STRESS University of Massachusetts (US) 2012-05-30 EP disclosed
WO-2011011092-A1 METHODS AND COMPOSITIONS TO REDUCE OXIDATIVE STRESS UNIVERSITY OF MASSACHUSETTS (US) 2011-01-27 WO disclosed
US-20060155178-A1 Multi-dimensional elastic light scattering NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-07-13 US disclosed
US-20060058257-A1 Influencing angiogenesis using CD66a WAGENER CHRISTOPH 2006-03-16 US disclosed
US-20040097521-A1 Clinical treatment NACTILUS AB (SE) 2004-05-20 US disclosed
US-20030108934-A1 21910, a novel human membrane-associated guanylate kinase and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-12 US disclosed
US-5541169-A FUNGICIDES KOWA COMPANY, LTD. (JP) 1996-07-30 US disclosed
EP-0632021-A1 AZOXY COMPOUND KOWA CO. LTD. (JP) 1995-01-04 EP disclosed